German Cosmetics Company Evertz Pharma Spends 10 Million Euros on 100 BTC

Evertz Pharma GmbH, a German company renowned for its premium natural cosmetics, has made a bold financial move that is capturing attention far beyond the beauty industry. 

In May 2025, the company added 100 Bitcoin (BTC)—valued at approximately €10 million (around $10.8 million USD)—to its corporate treasury. This landmark acquisition makes Evertz Pharma the first German company to adopt a strategic Bitcoin reserve model.

This article explores the significance of Evertz Pharma’s Bitcoin investment, the company’s broader treasury strategy, and how this move reflects a growing trend among private enterprises seeking to diversify and future-proof their financial assets.

Key Takeaways

• Evertz Pharma became the first German company to establish a strategic Bitcoin reserve by purchasing 100 BTC worth €10 million in May 2025.
• The company started its Bitcoin treasury in December 2020 with an initial €2 million investment and has consistently added to its holdings.
• Evertz Pharma views Bitcoin as a store of value, inflation hedge, and a way to diversify corporate reserves beyond traditional assets like gold.
• Unlike publicly traded companies, Evertz Pharma operates as a privately held firm, making this a unique and pioneering move in Germany’s private sector.
• The investment aligns with Evertz Pharma’s long-term vision of financial stability and sustainability in a modern business environment.
• Corporate profits are regularly allocated toward Bitcoin, demonstrating a clear commitment to digital asset adoption as part of the company’s core financial strategy.
• The move may inspire other private companies in Germany and beyond to consider Bitcoin as a strategic asset class for treasury diversification.

Register now on Bitrue — a trusted crypto exchange used by millions worldwide. Bitrue gives you access to hundreds of tokens, low-fee trading pairs, and high-yield staking opportunities. Whether you're buying Bitcoin, trading altcoins, or exploring new DeFi projects, Bitrue makes it easy to get started. Sign up today and start your crypto journey in minutes.

Evertz Pharma’s Bold Bitcoin Move: What It Means

Founded with a mission to promote natural beauty using scientific principles, Evertz Pharma has now extended that future-focused mindset into its financial strategy. 

Dominik Evertz, Managing Director, emphasizes that Bitcoin, due to its scarcity and global tradability, is the perfect complement to their reserves. This reflects a forward-looking approach in which digital assets play a key role in securing the company’s financial future.

The recent purchase of 100 BTC adds a substantial new layer to the company’s Bitcoin holdings, which began with a €2 million investment back in December 2020. 

Over the past five years, Evertz Pharma has continuously dedicated portions of its corporate profits to expanding this digital treasury.

Read more: Miners Backed by Trump Reveal Bitcoin Holdings — Is This Bullish for Trump Coin?

Bitcoin as a Strategic Corporate Asset

For Evertz Pharma, Bitcoin is not just an investment — it is a strategic asset. Several reasons underpin this perspective:

• Store of Value: Bitcoin’s limited supply of 21 million coins positions it as a deflationary asset, unlike fiat currencies subject to inflation.
• Inflation Hedge: By holding Bitcoin, Evertz Pharma protects its capital from the erosive effects of inflation on traditional currencies.
• Diversification: Bitcoin offers a novel way to diversify reserves, avoiding the storage costs and logistical challenges associated with traditional safe-haven assets like gold.
• Global Liquidity: Being a globally recognized asset, Bitcoin can be traded or transferred across borders with ease, providing financial flexibility.

This financial innovation signals a significant shift for German companies traditionally reliant on conventional assets for treasury management.

Evertz Pharma’s Financial Vision and Corporate Governance

Tobias Evertz, Group CFO, reiterated the company’s long-term commitment to Bitcoin, stating, “We will continue to invest corporate profits in Bitcoin and are constantly evaluating additional ways to increase our holdings sustainably.” 

This statement highlights the evolving nature of corporate treasury management and the growing acceptance of digital assets in mainstream business.

Unlike publicly traded firms such as Strategy or Metaplanet, which have also embraced Bitcoin reserves, Evertz Pharma remains a privately held enterprise. 

This distinction underscores the uniqueness of the company’s move, demonstrating that even non-public firms are recognizing Bitcoin’s strategic value.

Read more about Bitcoin (BTC):

Bitcoin Price (BTC), Market Cap, Price Today & Chart History

Bitcoin (BTC) Price Today

How to buy Bitcoin (BTC)

BTC to USD: Convert Bitcoin to US Dollar

How to Stake Bitcoin (BTC)

Wider Context: Bitcoin Adoption by Corporations

Evertz Pharma’s purchase is part of a larger wave of corporate Bitcoin adoption. Since MicroStrategy’s landmark move in 2020, dozens of companies across sectors—from technology and finance to retail and manufacturing—have allocated portions of their treasury into Bitcoin.

This trend reflects increasing institutional confidence in Bitcoin as a credible asset class and a hedge against macroeconomic uncertainty. It also highlights Bitcoin’s evolution from a speculative cryptocurrency to a key component of corporate finance.

Potential Impact on the German Market and Beyond

As the first German company to publicly announce a strategic Bitcoin reserve, Evertz Pharma is setting a precedent for the country’s private sector. This move could encourage other businesses in Germany and Europe to reconsider their treasury strategies in light of digital assets’ benefits.

Furthermore, Evertz Pharma’s success in blending a scientific and sustainable business philosophy with innovative financial practices might inspire companies worldwide to follow suit.

Read more: Is This a Sign of Onchain Bullish Activity? A Potential Start for Bitcoin’s Bull Market

Why This Matters to Investors and the Crypto Community

• Increased Corporate Adoption: Private and public company Bitcoin reserves enhance the asset’s legitimacy and encourage broader institutional investment.
• Market Stability: As more companies adopt Bitcoin for treasury purposes, the demand for BTC may stabilize prices and reduce volatility.
• Innovation in Treasury Management: Evertz Pharma exemplifies how companies can modernize financial strategies to incorporate digital assets responsibly.
• Long-term Vision: The company’s commitment signals confidence in Bitcoin’s future as a reliable store of value amid uncertain economic climates.

Conclusion

Evertz Pharma’s purchase of 100 BTC valued at €10 million marks a milestone for corporate Bitcoin adoption in Germany. By integrating Bitcoin into its treasury strategy, the company not only strengthens its long-term financial resilience but also champions innovation within the private sector.

This bold move highlights Bitcoin’s growing role as a strategic asset, inspiring other firms to consider digital currencies as part of their financial portfolios. As Bitcoin continues to weave deeper into corporate treasuries globally, Evertz Pharma stands out as a pioneering example of visionary leadership and financial foresight.

Read More: Bitcoin Price Prediction 2024–2030

Frequently Asked Questions (FAQs)

Q1: Why did Evertz Pharma invest in Bitcoin?

They view Bitcoin as a scarce, globally tradable asset that complements their reserves and offers long-term financial stability.

Q2: How much Bitcoin has Evertz Pharma accumulated?

The company purchased an initial €2 million worth of Bitcoin in 2020 and added 100 BTC (~€10 million) in May 2025.

Q3: Is Evertz Pharma publicly traded?

No, it is a privately held German cosmetics company.

Q4: How does Bitcoin help in treasury management?

Bitcoin acts as a store of value, inflation hedge, and diversifier, reducing reliance on traditional assets like gold.

Q5: Could other companies in Germany follow Evertz Pharma’s lead?

Yes, this move could inspire more German and European companies to adopt Bitcoin as part of their treasury strategy.